SCHEMBL687304

SCHEMBL687304

Cc1ccc(Cn2cc(C)c(O)c(NC(=O)N[C@@H](CC(=O)O)c3ccc(C)cc3)c2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 3/20 0.41
NFE2L2 Q16236 3/20 0.41
CYP26A1 O43174 2/20 0.39
ITGB1 P05556 6/20 0.39
ITGA4 P13612 6/20 0.39
CTSA P10619 4/20 0.38
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37
MEN1 O00255 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL687472 0.96 KMT2A (0.41) KEAP1NFE2L2CYP26A1ITGB1ITGA4
SCHEMBL687670 0.93 ITGB1 (0.38) KEAP1NFE2L2CYP26A1ITGB1ITGA4
SCHEMBL688301 0.90 PTGER4 (0.42) CTSAALDH1A1MAPT
SCHEMBL688495 0.89 POLB (0.39) KEAP1NFE2L2CYP26A1CTSALMNA
SCHEMBL688046 0.89 CTSA (0.42) KEAP1NFE2L2CYP26A1CTSAKDM4E
SCHEMBL29371834 0.88 PTGER3 (0.44) CTSA
SCHEMBL686896 0.88 PTGER3 (0.44) CTSA
SCHEMBL688146 0.87 CTSA (0.41) KEAP1NFE2L2CYP26A1CTSAKDM4E
SCHEMBL688251 0.87 CTSA (0.44) CYP26A1CTSAKDM4EALDH1A1MEN1
SCHEMBL688008 0.86 CTSA (0.41) CYP26A1CTSAALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed